Price$815.15+22.57 (+2.85%)
01:30 PM07:45 PM
News · 26 weeks29+500%
2025-11-022026-04-26
Mix2190d
- Insider8(38%)
- SEC Filings6(29%)
- Earnings2(10%)
- Leadership1(5%)
- Other3(14%)
- Offering1(5%)
Latest news
25 items- SECMcKesson Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - MCKESSON CORP (0000927653) (Filer)
- ANALYSTWilliam Blair initiated coverage on McKessonWilliam Blair initiated coverage of McKesson with a rating of Outperform
- PRMcKesson Corporation Declares Quarterly DividendThe Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and rea
- PRMcKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical SolutionsMcKesson Corporation (NYSE:MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo ("Apollo Funds"), under which Apollo Funds will acquire a minority ownership interest in McKesson's Medical-Surgical Solutions ("MMS") business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public offering. Apollo Funds will invest $1.25 billion in convertible preferred equity of MMS to acquire an approximately 13% minority interest in MMS. The transaction values MMS at approximately $13 billion total enterprise valuation. Mc
- INSIDERSEC Form 3 filed by new insider Fraga Francisco3 - MCKESSON CORP (0000927653) (Issuer)
- SECMcKesson Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - MCKESSON CORP (0000927653) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by McKesson CorporationSCHEDULE 13G/A - MCKESSON CORP (0000927653) (Subject)
- SECMcKesson Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - MCKESSON CORP (0000927653) (Filer)
- PRMcKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming ConferencesMcKesson Corporation (NYSE:MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026. McKesson Corporation has reaffirmed fiscal 2026 full year outlook as previously issued on Febru
- SECMcKesson Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MCKESSON CORP (0000927653) (Filer)
- PRMcKesson Announces Planned CFO TransitionBritt Vitalone announces retirement, Kenny Cheung named as successor McKesson Corporation (NYSE:MCK) today announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the company, including more than eight years as CFO. Looking ahead, Kenny Cheung will join McKesson as Executive Vice President and CFO, effective May 29, 2026. "Britt is an exceptional partner and leader. He has been instrumental in advancing the company's financial performance, engaging with shareholders, and instilling a culture of financial discipline," said Brian Tyler, Chief Executive Officer, McKesson Corporation
- INSIDEREVP and Chief Legal Officer Lau Michele sold $2,697,750 worth of shares (2,725 units at $990.00), decreasing direct ownership by 46% to 3,247 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERDirector Martinez Maria sold $328,013 worth of shares (349 units at $939.87), decreasing direct ownership by 54% to 301 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDEREVP & Chief HR Officer Smith Leann B sold $179,550 worth of shares (190 units at $945.00), decreasing direct ownership by 6% to 2,989 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDEREVP and Chief Legal Officer Lau Michele sold $282,817 worth of shares (303 units at $933.39), decreasing direct ownership by 5% to 5,972 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDEREVP & Chief HR Officer Smith Leann B converted options into 508 shares and covered exercise/tax liability with 129 shares, increasing direct ownership by 14% to 3,179 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDEREVP and Chief Legal Officer Lau Michele converted options into 4,748 shares and covered exercise/tax liability with 1,720 shares, increasing direct ownership by 93% to 6,275 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERSVP, Controller & CAO Rutledge Napoleon B Jr sold $313,240 worth of shares (328 units at $955.00), closing all direct ownership in the company (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- SECSEC Form 10-Q filed by McKesson Corporation10-Q - MCKESSON CORP (0000927653) (Filer)
- PRMcKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS GuidanceMcKesson Corporation (NYSE:MCK) has released its fiscal 2026 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 4 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at i
- SECMcKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MCKESSON CORP (0000927653) (Filer)
- PRMcKesson Corporation Completes Divestiture of Norwegian OperationsMcKesson Corporation (NYSE:MCK) announced today that it has closed the transaction to sell its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group. McKesson announced on August 4, 2025, that it planned to divest Norway, included within the Other segment. The transaction represents the final step in McKesson's commitment to fully exit its European operations. This transaction will enable McKesson to focus strategy and capital allocation on expanding and accelerating its growth platforms within Oncology and Multispecialty and Biopharma Services. Additional details related to the divestiture will be provided on the Company's Fiscal Third Quarter
- PRMcKesson Corporation Declares Quarterly DividendThe Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on April 1, 2026, to shareholders of record on March 2, 2026. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and r
- INSIDEREVP, Chief Strategy & BDO Rodgers Thomas L sold $225,266 worth of shares (276 units at $816.18), decreasing direct ownership by 11% to 2,268 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- PRMckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release DateMcKesson Corporation (NYSE:MCK) will release its third quarter fiscal 2026 financial results after market close on Wednesday, February 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to
MCK FAQ
7 questionsWhat does McKesson Corporation do?
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and...Where does MCK stock trade?
McKesson Corporation (MCK) is listed on NYSE.What sector and industry is MCK in?
McKesson Corporation operates in the Health Care sector, Other Pharmaceuticals industry.Does MCK pay a dividend?
Yes. MCK's next ex-dividend date is 2026-06-01 with a declared cash dividend of $0.82 per share, payable 2026-07-01.What are analysts saying about MCK?
McKesson Corporation has had 8 recent analyst actions on file. The most recent action was from William Blair: Outperform on 2026-04-28.What companies are similar to MCK?
Notable peers in the same industry include CAH (Cardinal Health Inc.), BDX (Becton Dickinson and Company), HSIC (Henry Schein Inc.). Compare MCK side-by-side with any of them on Quantisnow.How can I track MCK on Quantisnow?
Quantisnow aggregates McKesson Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MCK to receive live email and push alerts on every new disclosure.